These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32471192)

  • 1. Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer.
    Lipsey CC; Harbuzariu A; Robey RW; Huff LM; Gottesman MM; Gonzalez-Perez RR
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
    Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis.
    Fiorio E; Mercanti A; Terrasi M; Micciolo R; Remo A; Auriemma A; Molino A; Parolin V; Di Stefano B; Bonetti F; Giordano A; Cetto GL; Surmacz E
    BMC Cancer; 2008 Oct; 8():305. PubMed ID: 18945363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-mediated RNA interference targeting the ObR gene in human breast cancer MCF-7 cells in a nude mouse xenograft model.
    Xue RQ; Gu JC; DU ST; Yu W; Wang Y; Zhang ZT; Bai ZG; Ma XM
    Chin Med J (Engl); 2012 May; 125(9):1563-70. PubMed ID: 22800822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
    Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
    Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
    Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
    Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.
    Rene Gonzalez R; Watters A; Xu Y; Singh UP; Mann DR; Rueda BR; Penichet ML
    Breast Cancer Res; 2009; 11(3):R36. PubMed ID: 19531256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma.
    Fiedor E; Gregoraszczuk EL
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):815-827. PubMed ID: 28861689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli.
    Garofalo C; Koda M; Cascio S; Sulkowska M; Kanczuga-Koda L; Golaszewska J; Russo A; Sulkowski S; Surmacz E
    Clin Cancer Res; 2006 Mar; 12(5):1447-53. PubMed ID: 16533767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers.
    Révillion F; Charlier M; Lhotellier V; Hornez L; Giard S; Baranzelli MC; Djiane J; Peyrat JP
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2088-94. PubMed ID: 16609020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation analysis between the expressions of leptin and its receptor (ObR) and clinicopathology in endometrial cancer.
    Zhang Y; Liu L; Li C; Ai H
    Cancer Biomark; 2014; 14(5):353-9. PubMed ID: 25171477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance.
    Thiagarajan PS; Zheng Q; Bhagrath M; Mulkearns-Hubert EE; Myers MG; Lathia JD; Reizes O
    Endocr Relat Cancer; 2017 Aug; 24(8):415-426. PubMed ID: 28729467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.
    Strong AL; Ohlstein JF; Biagas BA; Rhodes LV; Pei DT; Tucker HA; Llamas C; Bowles AC; Dutreil MF; Zhang S; Gimble JM; Burow ME; Bunnell BA
    Breast Cancer Res; 2015 Aug; 17(1):112. PubMed ID: 26286584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ObRb downregulation increases breast cancer cell sensitivity to tamoxifen.
    Qian Y; Shi D; Qiu J; Zhu F; Qian J; He S; Shu Y; Yin Y; Chen X
    Tumour Biol; 2015 Sep; 36(9):6813-21. PubMed ID: 25846733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages.
    Wang Y; Wan R; Hu C
    Mol Med; 2023 Jul; 29(1):100. PubMed ID: 37488474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the leptin receptors expression in breast cancer cell lines exposed to leptin and tamoxifen.
    Linares RL; Benítez JGS; Reynoso MO; Romero CG; Sandoval-Cabrera A
    Sci Rep; 2019 Dec; 9(1):19189. PubMed ID: 31844100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells.
    Garofalo C; Sisci D; Surmacz E
    Clin Cancer Res; 2004 Oct; 10(19):6466-75. PubMed ID: 15475434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy.
    Riolfi M; Ferla R; Del Valle L; Piña-Oviedo S; Scolaro L; Micciolo R; Guidi M; Terrasi M; Cetto GL; Surmacz E
    Brain Pathol; 2010 Mar; 20(2):481-9. PubMed ID: 19775291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.